Condition
Stage IV Uterine Corpus Cancer AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Stage IV Uterine Corpus Cancer AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Stage IV Uterine Corpus Cancer AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Treatment of advanced solid tumors with IACS-6274 and other medications | Phase 1 | Houston, Texas | Recruiting | Sep 10, 2021 |
| Using pressurized aerosol chemotherapy to treat advanced abdominal cancers | Phase 1 | Duarte, California and 2 other locations | Recruiting | Apr 1, 2020 |
| Combining talazoparib with radiation therapy for recurrent gynecologic cancers | Phase 1 | Baltimore, Maryland and 1 other locations | Recruiting | May 30, 2019 |
All recruiting trials (4)
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Treatment of advanced solid tumors with IACS-6274 and other medications
This study is testing a new drug called IACS-6274, alone and with other medications, to see how well it can help people with advanced solid tumors and what the safest dose is.
-
Using pressurized aerosol chemotherapy to treat advanced abdominal cancers
This study is testing a new way to deliver chemotherapy directly into the abdomen using a special aerosol spray to see if it helps people with advanced abdominal cancers feel better and have fewer side effects.
-
Combining talazoparib with radiation therapy for recurrent gynecologic cancers
This study is testing if combining a drug called talazoparib with radiation therapy can safely help people with recurrent gynecologic cancers feel better.
Related topics
Quick answers
How many Stage IV Uterine Corpus Cancer AJCC v8 clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.